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Abstract
Background:  Hepato-biliary tract lithiasis is common and present either as pain or as
asymptomatic on abdominal ultrasonography for other causes. Although the DNA of Helicobacter
species are identified in the gallbladder bile, tissue or stones analyzed from these cases, still a causal
relationship could not be established due to different results from different geographical parts.
Methods: A detailed search of pubmed and pubmedcentral was carried out with key words
Helicobacter  and gallbladder, gallstones, hepaticolithiasis, cholelithiasis and choledocholithiasis,
benign biliary diseases, liver diseases. The data was entered in a data base and meta analysis was
carried out. The analysis was carried out using odds ratio and a fixed effect model, 95% confidence
intervals for odds ratio was calculated. Chi square test for heterogeneity was employed. The
overall effect was calculated using Z test.
Results: A total of 12 articles were identified. One study used IgG for diagnosis while others used
the PCR for Ure A gene, 16 S RNA or Cag A genes. A couple of studies used culture or
histopathology besides the PCR. The cumulative results show a higher association of Helicobacter
with chronic liver diseases (30.48%), and stone diseases (42.96%)(OR 1.77 95% CI 1.2–2.58; Z =
2.94, p = 0.003), the effect of each could not be identified as it was difficult to isolate the effect of
helicobacter due to mixing of cases in each study.
Conclusion: The results of present meta analysis shows that there is a slight higher risk of
cholelithiasis and benign liver disease (OR 1.77), however due to inherent inability to isolate the
effect of stone disease from that of other benign lesions it is not possible to say for sure that
Helicobacter has a casual relationship with benign biliary disease or stone disease or both.
Background
The benign diseases of the hepatobiliary system and the
stone disease is one of the common problems encoun-
tered in some parts of the world. Some of the causes of bil-
iary lithiasis are known while others are still being
debated. Infection of the biliary tract has also been sus-
pected to lead to stone formation, which is also been
described as tomb of a bacteria. There is an increasing con-
cern that preexisting untreated stone disease could lead to
malignancy in long run [1].
Although Helicobacter species are identified in the bile, tis-
sue and stones of the patients with stone disease and the
benign biliary diseases, due to differing results that have
been obtained from different geographical regions no
causative relationship could be established till date [2].
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This article systematically reviews the evidence available
on the role of Helicobacter species in benign diseases and
biliary tract lithiasis and presents a meta analysis of
results.
Methods
A detailed pubmed search was made using key words
'hepatobiliary', 'biliary','gallbladder' and 'neoplasia', or
'tumor', stone, lithiasis, cholelithiasis, hepaticolithiasis,
choledocholithiasis, gallstone and Helicobacter. The search
was then limited to humans. The articles were carefully
read and were classified into observational or case-control
study type. The data on method of detection, number of
positive cases for Helicobacter in subjects and controls and
the type of organisms identified were extracted and
entered in the database prepared for the purpose. Total
samples analyzed in the study were taken into account
irrespective of methods of detection used. If a study used
three methods of detection, the sample of all the three
methods was summed to get total number and number of
positive cases. No attempt was made to study the effect of
method of detection in the present analysis. Meta analysis
was carried out for the above data from the case control
studies despite their heterogeneity with the goal that if an
association is observed in this meta analysis this will help
in designing further studies and will also help in under-
standing what kind of studies are exactly required.
Meta analysis was carried out using odds ratio and a fixed
effect model, 95% confidence intervals for odds ratio was
calculated. Chi square test for heterogeneity was
employed. The overall effect was calculated using Z test.
Results
The abstract of each article was screened by author and a
total of 12 articles that were found to be relevant were
identified [3-14]. These articles form the basis of the
present review. The salient features of these articles on
methodology, diseases studied and results are summa-
rized in table 1.
Of the case control studies, 8 studies were purely on gall-
stone disease [5-7,10-14] (table 1; figure 1), While 4 oth-
ers examined the population with stones beside either
other chronic diseases or malignancies of biliary tract
[3,4,8,9]. The cumulative sample size of these 12 studies
was 797 of which 322 (40.4%) were positive for Helico-
bacter species. The positivity in the controls was 145/615
(23.5%). One study each used UreA gene analysis and 26
kDa antigen for identification of Helicobacter, another
used CagA, while rest used 16s rRNA or DNA based PCR.
Positivity in biliary epithelium was much higher 40–
62.5% [3,5] compared to that in bile. Seven of these iden-
tified H. pylori, one study identified Campylobacter sp while
two identified H. bilis, and rest identified Helicobacter sp.
The positivity rate among controls was 23.5%. Of the 9
studies where the sample size of lithiasis patients was
available 272/633 samples from cases and 118/268 sam-
ples from controls were positive. The cumulative odds
ratio of these studies was 1.77 (95% CI 1.21–2.58) (Z =
2.94, p = 0.003). Three studies looked at the patients with
benign hepato-biliary diseases. Addition of these studies
raised the sample size to 797 cases and 615 controls. The
odds ratio after addition of these studies increased to 2.46
(95% CI 1.8–3.36; I2 76%, Z = 5.68) (figure 2). It was
found that the study of Figura et al., [13] used Cag A in bile
and gallstones for detection of H pylori and contributed
nearly 1/3 of the weight in the overall effect due to its large
sample size. Exclusion of this study from the estimation
lead to Odds of 2.16 [95% CI 1.35–3.45] in stone disease
with I2 of 65.3% Z value of 3.22 (p = 0.001) and odds of
3.05 [95% CI 2.13–4.36] in benign diseases including
stones with I2 of 71.7% and Z value of 6.08 (p < 0.0001).
Thus increase in odds was observed for both groups by
exclusion of this study (Figure 3 and 4).
Discussion
The genus of Helicobacter has expanded to include number
of species [15]. The most studied among these is Helico-
bacter pylori (H. Pylori), that colonizes the stomach and
has been found to be associated with benign diseases like
gastritis [16], and peptic ulcer disease [17]. H. pylori is a
spiral highly motile microaerophillic organism, uniquely
adopted to survive by burrowing into the mucous layer
when it is well protected from the host environment.
Some other species like H. hepaticus and H. bilis have been
shown to infect the liver and the presence of them has
been associated with hepatitis and hepatobiliary neo-
plasms [1,15,18,19].
The complete genomic sequence of H. Pylori and H. hepat-
icus is now known. With the identification of H. pylori the
paradigm for the management of peptic ulcer, chronic
gastritis, MALT lymphoma and gastric adenocarcinoma
has undergone paradigm shift [20,21]. The H pylori infec-
tion is now also been implicated in diverse conditions like
coronary artery disease, autoimmune thrombocytopenia,
skin diseases, and growth retardation in children [22-25].
The Helicobacter sp have been reported to survive in bile
juice and that has prompted people to think "could this
bacterial colonization of bile be responsible for hepato-
biliary disease"? Helicobacter species has been identified in
bile juice of patients with cholelithiasis, primary scleros-
ing cholangitis and primary biliary cirrhosis
[26,27,4,28,29].
It is also proposed that Helicobacter may also promote the
risk of stone formation by acting as a foreign body to formWorld Journal of Surgical Oncology 2007, 5:94 http://www.wjso.com/content/5/1/94
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a
 nidus around which the stone may develop or it may pro-
duce hydrolyzing enzymes or neucleating proteins like
immunoglobulins. CagA protein of Helicobacter has been
found to have a homology with aminopeptidase and
hence can increase the gallstone formation. Beside these
Helicobacter sp. Have also been proposed to increase the
lithogenicity by production of soluble antigens that may
bind to and inhibit key hepatobiliary genes like muc [31].
T
his may lead to modulation of enterohepatic cycling of
conjugated bile acids through genetic regulation of
absorption at enterocyte level or modulation of the transit
time through gut [31]. Host response to Helicobacter anti-
gens in form of cytokines, and other inflammatory medi-
ators are also proposed to play a role [31]. However, the
exact mechanism and exact role played by Helicobacter is
still speculated. The results of present meta analysis show
Table 1: Characteristics of case control studies on Helicobacter sp in benign hepatobiliary diseases and stone diseases.
Reference and year Method of 
detection
Specimen Disease Helicobacter in 
subjects n/N
Helicobacter in 
controls n/N
Organism 
identified
Myung et al 2000 [3] PCR (UreA) (26 kDa 
Ag)
Intrahepatic Bile, 
biliary duct tissue, 
gallbladder
Hepatobiliary diseases 4/43 ureA
5/43 26 kDa
0/8
0/23
H. Pylori
Nilsson et al 2000 [4] PCR (16s rRNA) Liver PSC
PBC
9/12
11/12
0/10 control
1/13 NCLC
H. Sp.
Harada et al 2001 [5] PCR (16s rRNA) Bile, biliary epithelium Intrahepatic calculi 3/14 bile
5/8 biliary epithelium
0/9
0/7
Campylobacter sp.
Leong et al 2001 [6] PCR (16s rRNA) Bile CBD stone
Cholangitis
4/25 0/4 H. Sp.
Presser Silva et al 
2003 [7]
Culture PCR (16s 
rRNA)
Bile
Gallbladder tissue
Cholelithiasis 20/64 culture
28/51 histology
24/56 bile
2/18 H pylori
Chen W et al 2003 
[8]
PCR Gallbladder Gall stones 29/60 symptomatic
6/10 asymptomatic
15/37 Helicobacter pylori
Vorojova T et al 2006 
[9]
IgG Elisa Serum Chronic liver disease 13/35
7/32
1/27
4/81; 0/16
7/84; 0/6
12/89; 3/17
H. hepaticus
H. bilis
H. pullorum
Abayli et al 2005 [10] 16s rRNA
PCR
HPE
GB stone Cholesterol stones 7/77 6/20 H pylori
Farshad Sh et al 2004 
[11]
16s RNA Stones Bile Gall stones 6/33 stones
4/33 bile
0/40 H pylori
H spp
Bulajic et al 2002 [12] ureA gene PCR Bile Biliary lithiasis 
cholengitis
26/48 stone
9/17 cholangitis
1/7 H Pylori
Figura et al 1998 [13] CagA Bile gallstones 92/112 90/112 H. pylori
Matsukura et al 2002 
[14]
PCR 16s rRNA Bile Biliary tract cancer 
Gallstones
24/29 malignant 18/42 
stone
4/14 H bilis
Chr. – chronic; CaGB – gallbladder cancer; CC – cholangiocarcinoma; HCC – hepatocellular carcinoma
PSC – Primary sclerosing cholangitis; PBC – primary biliary cirrhosis; CBD – common bile duct; GB – gallbladder
Results of Meta analysis of 9 studies on lithiasis patients as cases Figure 1
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Results of Meta analysis of 12 studies on lithiasis and benign biliary diseases including chronic liver diseases Figure 2
Results of Meta analysis of 12 studies on lithiasis and benign biliary diseases including chronic liver diseases.
Results of meta analysis of 8 studies on lithiasis after exclusion of study of Figura et al on CAg A protein Figure 3
Results of meta analysis of 8 studies on lithiasis after exclusion of study of Figura et al on CAg A protein.
Results of meta analysis of 11 studies on lithiasis and benign biliary diseases after exclusion of study of Figura et al on CAg A protein Figure 4
Results of meta analysis of 11 studies on lithiasis and benign biliary diseases after exclusion of study of Figura et al on CAg A protein.World Journal of Surgical Oncology 2007, 5:94 http://www.wjso.com/content/5/1/94
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a positive association of helicobacter with benign biliary
diseases and lithiasis, however further case control studies
are needed to further elucidate their relationship.
Conclusion
The results of meta analysis suggest that the Helicobacter
may play a role however due to heterogeneity of the sam-
ple and variations in the methodology for detecting Heli-
cobacter these results should be seen with skeptic view and
further studies are warranted to definitely answer the
question.
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